Table 1.
Participant characteristics and results of the SARA, BBS, and TUG tests
| No | Disease type | Age (y)/sex | SARA scores | BBS scores | TUG tests | |||
|---|---|---|---|---|---|---|---|---|
| Day 0 | Day 14 | Day 0 | Day 14 | Day 0 | Day 14 | |||
| 1 | SCA6 | 45/M | 14.0 | 12.5 | 30 | 34 | 21.4 | 24.5 |
| 2 | IDCA | 77/M | 9.5 | 7.5 | 44 | 53 | 18.6 | 11.0 |
| 3 | MSA-C | 65/F | 5.0 | 3.5 | 51 | 53 | 12.6 | 10.2 |
| 4 | IDCA | 56/F | 8.0 | 8.0 | 45 | 45 | 15.1 | 13.8 |
| 5 | ADCA | 57/F | 7.5 | 7.0 | 49 | 51 | 6.8 | 8.3 |
| 6 | SCA6 | 51/F | 8.0 | 8.0 | 39 | 44 | 14.5 | 13.4 |
| 7 | MSA-C | 48/M | 13.0 | 12.0 | 35 | 36 | 28.4 | 19.0 |
| 8 | SCA6 | 61/F | 13.5 | 12.0 | 35 | 40 | 25.1 | 22.7 |
| 9 | MSA-C | 72/F | 13.5 | 11.5 | 33 | 39 | 26.5 | 20.6 |
| 10 | SCA36 | 57/M | 14.5 | 14.5 | 45 | 44 | 34.1 | 25.1 |
| 11 | MSA-C | 74/F | 10.5 | 14.0 | 36 | 41 | 16.5 | 16.4 |
| 12 | SCA31 | 72/M | 19.5 | 21.0 | 34 | 19 | 43.1 | 32.4 |
| 13 | SCA31 | 63/M | 9.0 | 8.5 | 49 | 52 | 13.2 | 11.4 |
| 14 | SCA2 | 50/F | 11.0 | 11.0 | 37 | 40 | 14.1 | 12.3 |
| 15 | IDCA | 69/M | 14.0 | 14.5 | 42 | 43 | 17.8 | 14.5 |
| 16 | ADCA | 69/F | 2.0 | 2.0 | 53 | 54 | 10.2 | 8.9 |
| 17 | ADCA | 75/F | 9.0 | 13.0 | 45 | 50 | 18.9 | 16.1 |
| 18 | MSA-C | 69/F | 10.0 | 9.0 | 36 | 37 | 19.3 | 17.1 |
| Mean ± SD | 10.6 ± 4.0 | 10.5 ± 4.4 | 41.0 ± 6.9 | 43.1 ± 8.7 | 19.8 ± 8.9* | 16.5 ± 6.5* | ||
ADCA autosomal dominant cerebellar ataxia without genetic testing, BBS Berg Balance Scale, IDCA idiopathic cerebellar ataxia, MSA-C multiple system atrophy with predominant cerebellar ataxia, SARA Scale for the Assessment and Rating of Ataxia, SCA spinocerebellar ataxia, SD standard deviation, TUG timed up and go
*Statistically significant difference